Serratiopeptidase PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Serratiopeptidase PCD pharma franchise company offering a portfolio of 11 Serratiopeptidase formulations across tablets. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.
What is Serratiopeptidase?
Serratiopeptidase is a proteolytic enzyme originally isolated from Serratia species. It hydrolyses bradykinin, fibrin and other inflammatory mediators at the site of injury, and is used as an anti-inflammatory and anti-oedema adjunct rather than as an analgesic in its own right. The compound record can be reviewed on PubChem.
Therapeutic Applications
Post-operative and post-traumatic swelling, dental and maxillofacial surgery, sinusitis and otorhinolaryngological inflammation, and soft-tissue injury. It is used almost entirely in fixed-dose combination with NSAIDs such as diclofenac, aceclofenac or paracetamol.
Prescribed by: Orthopaedic surgeons, dental surgeons, ENT specialists and general surgeons are the leading prescribers of Serratiopeptidase combinations.
Why Serratiopeptidase is a High-Potential Molecule for Distributors
Serratiopeptidase travels with the analgesic prescription rather than competing with it, and that is what makes it commercially attractive: the NSAID-serratiopeptidase combination is close to a default in Indian orthopaedic, dental and ENT practice after surgery or injury. It raises the value of the pack over a plain NSAID while remaining affordable, and prescriptions are frequent and non-seasonal. For a distributor already carrying an analgesic range, adding eleven serratiopeptidase combination formulations is a low-friction way to lift value per prescription across the same prescriber base.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers its Serratiopeptidase franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Serratiopeptidase business in your region.
References
- PubChem – Serratiopeptidase compound record, US National Library of Medicine
- PubMed – clinical literature on Serratiopeptidase, NCBI
Our formulations of Serratiopeptidase find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: